Screening and Eligibility
Part of Clinical Research Coordinator (CRC) Training: Recruitment, Screening and Enrollment.
About 6 minutes. Free, in your language, no account needed.
Why this matters
Enrolling an ineligible participant is one of the most damaging errors a site can make. It exposes a person to risk the protocol did not assess for them, and it puts data into the study that may have to be excluded or explained.
It is also one of the easiest errors to make, because it usually happens through small, reasonable steps: a value close to the threshold, a test done a day late, a history nobody checked.
Pre-screening and screening
Pre-screening is the assessment done before consent, using information you already lawfully hold or that a person volunteers. It filters out people who obviously cannot take part. Keep it limited: until a person has consented, you may not perform study-specific procedures on them.
Screening is the formal assessment after consent, against the protocol's criteria. It happens within a defined screening window and produces a documented decision.
The order is fixed. Consent first, then any study-specific procedure. If a test is done only because of the study, it may not happen before consent. If a test would have been done anyway as part of routine care, the protocol will say whether its result may be used.
Inclusion and exclusion criteria
Inclusion criteria are the conditions a person must meet. Every one of them must be satisfied.
Exclusion criteria are the conditions that disqualify. Every one of them must be absent.
Both are absolute. There is no such thing as being nearly eligible, and there is no such thing as an eligibility criterion an investigator may waive. If a criterion appears wrong for a particular person, the route is to ask the sponsor, not to interpret it locally.
Criteria commonly exist to:
- Make sure the study population actually has the condition being studied.
- Protect people for whom the treatment could be dangerous.
- Remove factors that would make the results uninterpretable, such as a competing treatment.
How eligibility errors happen
Learn this list; it is the origin of most eligibility deviations.
- Threshold misreading. "Greater than 140" and "140 or above" are different rules.
- Wrong measurement method. The protocol specifies rest periods, repeats, posture, fasting state or a particular device, and a shortcut is taken.
- Out-of-window assessments. A screening test done outside the permitted period before randomization.
- Missing history. Prior therapies, another trial, or a diagnosis held elsewhere that nobody checked for.
- Outdated checklist. The eligibility checklist from an earlier protocol version is still in use.
- Local laboratory ranges. Deciding on a value without checking it against the reference range the protocol requires.
- Time pressure. The single largest contributing factor.
Working the eligibility checklist
- Use the checklist for the current protocol version, and check the version number on it.
- Work through every criterion in order. Do not skip criteria you believe you already know.
- For each one, record the source of the answer: which laboratory report, which clinic note, which measurement, on which date.
- Where a criterion depends on a value, write the value down, not just "met".
- Where a criterion depends on clinical judgment, the investigator decides and signs. This is a medical decision.
- Have a second person check the completed checklist before randomization. Two-person verification before randomization prevents more errors than any other single practice.
- The investigator signs and dates the eligibility confirmation before randomization.
Screen failures
A person who is screened and found ineligible is a screen failure. This is a normal outcome, not a mistake.
- Record the reason, specifically. "Did not meet inclusion criterion 4: eGFR below threshold" is useful; "not eligible" is not.
- Keep the screening log complete. Screen failures are part of the study's record and often part of the site's payment.
- Follow the protocol on re-screening. Some studies permit it under defined conditions; others do not. Never re-screen simply to obtain a better number.
- Tell the person clearly and kindly, and make sure any clinically relevant finding is passed to their usual doctor.
If an ineligible person is enrolled
It happens. What matters is what you do next.
- Tell the investigator immediately.
- Assess safety first. Does this person face a risk that the protocol did not anticipate?
- Notify the sponsor, and the ethics committee where local rules require it.
- Record it as a protocol deviation, with the facts and the date of discovery.
- Follow the sponsor's decision on whether the participant continues.
- Find the cause and fix it, rather than treating it as one person's mistake.
Never quietly correct a record to make an ineligible person look eligible. That is falsification, and it is a different category of problem entirely.
In practice
Nadia screens a woman for VT-201 whose eGFR is 44. The protocol excludes anyone below 45.
She is one unit outside, she is keen, and she would be an excellent participant. Dr. Osei is comfortable clinically. Everyone would like to enroll her.
Nadia records her as a screen failure with the specific reason and the laboratory report reference. She does not ask for a repeat test in the hope of a better number, because the protocol does not provide for that and the intention would be visible in the record.
She does raise the criterion with Marcus, the monitor, noting that several candidates have failed on the same threshold. That feedback goes to the sponsor and contributes to a later amendment. The amendment changes the criterion prospectively, for people screened afterwards.
The woman who was 44 is not enrolled retrospectively. Nadia calls her to explain, and passes the kidney result to her general practitioner.
An eligibility criterion is a boundary, not a target to be negotiated toward.
Key takeaways
- Consent comes before any study-specific procedure, including screening tests done only because of the study.
- All inclusion criteria must be met and all exclusion criteria must be absent; there is no partial eligibility and no investigator waiver.
- Record the source and the value behind every eligibility answer, not merely that the criterion was met.
- The investigator signs eligibility confirmation before randomization, and two-person verification before randomization prevents more errors than any other single practice.
- Screen failures are normal and must be logged with a specific reason, and an ineligible enrollment is reported and investigated rather than quietly corrected.